CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Tamoxifen - managing adverse effects - Management
What should I advise a woman taking tamoxifen?
- Encourage the woman to continue taking tamoxifen unless told otherwise by her specialist.
- Advise that there is a small risk of endometrial cancer and thrombotic disease (such as deep vein thrombosis).
- Although the benefits of treatment outweigh the risks, women should be advised to report any abnormal vaginal bleeding, or symptoms of thromboembolism (such as pain in the calf of one leg, and sudden breathlessness).
© NHS Institute for Innovation and Improvement